Article
Carfilzomib Triggers Cell Death in Chronic Lymphocytic Leukemia by Inducing Proapoptotic and Endoplasmic Reticulum Stress Responses.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Sept 2016
Lamothe Betty, Wierda William G, Keating Michael J, Gandhi Varsha
Abstract excerpt
PURPOSE: Carfilzomib, while active in B-cell neoplasms, displayed heterogeneous response in chronic lymphocytic leukemia (CLL) samples from patients and showed interpatient variability to carfilzomib-induced cell death. To understand this variability and predict patients who would respond to carfilzomib, we investigated the mechanism by which carfilzomib induces CLL cell death. EXPERIMENTAL DESIGN: Using CLL...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
